Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H19N |
Molecular Weight | 261.3609 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4
InChI
InChIKey=ISFHAYSTHMVOJR-UHFFFAOYSA-N
InChI=1S/C19H19N/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14/h2-10,19H,11-13H2,1H3
DescriptionSources: https://www.drugs.com/mtm/phenindamine.htmlCurator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18907211
Sources: https://www.drugs.com/mtm/phenindamine.html
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18907211
Phenindamine (thephorin or 2-methyl-9-phenyl-2,3,4,9-tetrahydro-1-pyridindene) a pyridindene derivative proved to be a potent antihistaminic. Phenindamine was used to treat sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL231 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | THEPHORIN Approved UsePhenindamine was used to treat sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold. Launch Date1947 |
PubMed
Title | Date | PubMed |
---|---|---|
Treatment of allergic and some other dermatoses with thephorin; a preliminary report. | 1947 Aug |
|
Histamine and the antihistaminic drugs. | 1950 May |
|
The effects of phenindamine tartrate on sleepiness and psychomotor performance. | 1992 Dec |
|
The histamine H1-receptor antagonist binding site. A stereoselective pharmacophoric model based upon (semi-)rigid H1-antagonists and including a known interaction site on the receptor. | 1995 Aug 18 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QR06AX04
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
||
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
||
|
WHO-ATC |
R06AX04
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C87745
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL278398
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
772BQ8KSST
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
4170
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
Phenindamine
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
11291
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
33283
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | RxNorm | ||
|
PHENINDAMINE
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
m8617
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB01619
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
C005430
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
DTXSID0023452
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
100000082235
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
SUB09764MIG
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
82-88-2
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
201-443-4
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY | |||
|
2129
Created by
admin on Fri Dec 15 15:07:13 GMT 2023 , Edited by admin on Fri Dec 15 15:07:13 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)